U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07828639) titled 'A Study of VC005 Tablets in Adolescent Subjects With Non-Segmental Vitiligo' on Sept. 15.
Brief Summary: This study is a multicenter, open-label, non-randomized study designed to evaluate the pharmacokinetics (PK), safety, and preliminary efficacy of VC005 tablets in adolescent subjects with Non-Segmental Vitiligo
Study Start Date: Sept. 25
Study Type: INTERVENTIONAL
Condition:
Non-Segmental Vitiligo
Intervention:
DRUG: VC005 tablets
VC005 repeat administration for up to 24 weeks
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Jiangsu vcare pharmaceutical technology co., LTD
Published by HT Digital Content Services with p...